Ju Fu Tang Biotech Holdings Co., Ltd (formerly “WMHW Holdings Limited”) has issued a proxy form outlining six ordinary resolutions to be tabled at its annual general meeting scheduled for 11:00 a.m. on 10 September 2026 at Portion 2, 12/F, The Center, 99 Queen’s Road Central, Hong Kong.

Key proposals:

1. Financial statements • Shareholders will be asked to receive and adopt the audited consolidated financial statements, together with the directors’ and auditors’ reports, for the financial year ended 31 March 2026.

2. Board remuneration and re-elections • The board seeks authority to determine directors’ remuneration. • Re-election of two directors: Ms. Yu Xiao (executive director) and Ms. Lao In Iam (independent non-executive director).

3. Auditor re-appointment • Infinity CPA Limited is nominated for re-appointment as external auditor, with the board empowered to fix its remuneration.

4. Share mandates • Issue Mandate: authorisation for the board to allot, issue and deal with additional shares up to 20% of the company’s issued share capital on the date of the resolution. • Repurchase Mandate: approval to repurchase shares up to 10% of the issued share capital. • Extension Mandate: conditional approval to increase the Issue Mandate by the number of shares repurchased under the Repurchase Mandate.

Shareholders may appoint the chairman or another proxy to vote on their behalf; proxy forms must reach Tricor Investor Services Limited at least 48 hours before the meeting. Attendance in person is permitted and supersedes submitted proxies.